Researchers Uncover How Aspirin Inhibits Bowel Cancer
Researchers have revealed how aspirin inhibits colorectal cancer by activating tumor-suppressing microRNAs, offering potential for its use as a preventive and therapeutic agent, especially in cancers where the p53 pathway is compromised.Researchers at LMU have discovered a signaling pathway through which aspirin can can inhibit colorectal cancer.Colorectal cancer, also known as bowel cancer, ranks as the world’s third most prevalent cancer type, with approximately 1.9 million new cases and 900,000 fatalities annually.…